Posted by Michael Wonder on 24 Jan 2022
Australians with severe dermatitis to benefit from PBS listing
24 January 2022 - From 1 February 2022, Australians with severe atopic dermatitis will have access to a new treatment listed on the Pharmaceutical Benefits Scheme.
Australians aged 12 years or older living with this form of dermatitis will benefit from the extended listing of Rinvoq (upadacitinib) on the PBS.
